Özdemir, M.; Gököz Doğu, G.; Yapar Taşköylü, B.; Demiray, A.G.; Yaren, A.; Değirmencioğlu, S.
Lymphocyte-Associated Inflammation Markers Predict Bleomycin-Induced Pulmonary Toxicity in Testicular Cancer. J. Clin. Med. 2025, 14, 7926.
https://doi.org/10.3390/jcm14227926
AMA Style
Özdemir M, Gököz Doğu G, Yapar Taşköylü B, Demiray AG, Yaren A, Değirmencioğlu S.
Lymphocyte-Associated Inflammation Markers Predict Bleomycin-Induced Pulmonary Toxicity in Testicular Cancer. Journal of Clinical Medicine. 2025; 14(22):7926.
https://doi.org/10.3390/jcm14227926
Chicago/Turabian Style
Özdemir, Melek, Gamze Gököz Doğu, Burcu Yapar Taşköylü, Atike Gökçen Demiray, Arzu Yaren, and Serkan Değirmencioğlu.
2025. "Lymphocyte-Associated Inflammation Markers Predict Bleomycin-Induced Pulmonary Toxicity in Testicular Cancer" Journal of Clinical Medicine 14, no. 22: 7926.
https://doi.org/10.3390/jcm14227926
APA Style
Özdemir, M., Gököz Doğu, G., Yapar Taşköylü, B., Demiray, A. G., Yaren, A., & Değirmencioğlu, S.
(2025). Lymphocyte-Associated Inflammation Markers Predict Bleomycin-Induced Pulmonary Toxicity in Testicular Cancer. Journal of Clinical Medicine, 14(22), 7926.
https://doi.org/10.3390/jcm14227926
